These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1618799)

  • 1. Thyroid hormone receptor mutants that cause resistance to thyroid hormone. Evidence for receptor competition for DNA sequences in target genes.
    Nagaya T; Madison LD; Jameson JL
    J Biol Chem; 1992 Jun; 267(18):13014-9. PubMed ID: 1618799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations.
    Nagaya T; Eberhardt NL; Jameson JL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):982-90. PubMed ID: 8408475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
    Meier CA; Dickstein BM; Ashizawa K; McClaskey JH; Muchmore P; Ransom SC; Menke JB; Hao EH; Usala SJ; Bercu BB
    Mol Endocrinol; 1992 Feb; 6(2):248-58. PubMed ID: 1569968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance.
    Nagaya T; Jameson JL
    J Biol Chem; 1993 Jul; 268(21):15766-71. PubMed ID: 8340402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
    Tagami T; Jameson JL
    Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes.
    Katz D; Lazar MA
    J Biol Chem; 1993 Oct; 268(28):20904-10. PubMed ID: 8407924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An artificial thyroid hormone receptor mutant without DNA binding can have dominant negative effect.
    Liu RT; Suzuki S; Takeda T; DeGroot LJ
    Mol Cell Endocrinol; 1996 Jun; 120(1):85-93. PubMed ID: 8809742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
    Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
    J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation.
    Takeda K; Balzano S; Sakurai A; DeGroot LJ; Refetoff S
    J Clin Invest; 1991 Feb; 87(2):496-502. PubMed ID: 1991834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome.
    Adams M; Nagaya T; Tone Y; Jameson JL; Chatterjee VK
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):281-9. PubMed ID: 1563081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
    Kitajima K; Nagaya T; Jameson JL
    Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activity of a mutant thyroid hormone receptor beta in a family with generalized resistance to thyroid hormone.
    Shuto Y; Okazaki T; Wakabayashi I
    Mol Cell Endocrinol; 1992 Dec; 90(1):111-5. PubMed ID: 1301392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.
    Chatterjee VK; Nagaya T; Madison LD; Datta S; Rentoumis A; Jameson JL
    J Clin Invest; 1991 Jun; 87(6):1977-84. PubMed ID: 2040690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.
    Collingwood TN; Wagner R; Matthews CH; Clifton-Bligh RJ; Gurnell M; Rajanayagam O; Agostini M; Fletterick RJ; Beck-Peccoz P; Reinhardt W; Binder G; Ranke MB; Hermus A; Hesch RD; Lazarus J; Newrick P; Parfitt V; Raggatt P; de Zegher F; Chatterjee VK
    EMBO J; 1998 Aug; 17(16):4760-70. PubMed ID: 9707435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
    Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
    Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone.
    Jameson JL
    Thyroid; 1994; 4(4):485-92. PubMed ID: 7711514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing a point mutation identified in a patient with pituitary resistance to thyroid hormone (Arg 338 to Trp) into other mutant thyroid hormone receptors weakens their dominant negative activities.
    Ando S; Nakamura H; Sasaki S; Nishiyama K; Kitahara A; Nagasawa S; Mikami T; Natsume H; Genma R; Yoshimi T
    J Endocrinol; 1996 Nov; 151(2):293-300. PubMed ID: 8958790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.